» Articles » PMID: 28674538

Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure

Overview
Journal Front Immunol
Date 2017 Jul 5
PMID 28674538
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Congestive heart failure (CHF) has become a major medical problem in the western world with high morbidity and mortality rates. CHF adversely affects several systems, mainly the kidneys and the lungs. While the involvement of the renin-angiotensin-aldosterone system and the sympathetic nervous system in the progression of cardiovascular, pulmonary, and renal dysfunction in experimental and clinical CHF is well established, the importance of pro-inflammatory mediators in the pathogenesis of this clinical setting is still evolving. In this context, CHF is associated with overexpression of pro-inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-1, and IL-6, which are activated in response to environmental injury. This family of cytokines has been implicated in the deterioration of CHF, where it plays an important role in initiating and integrating homeostatic responses both at the myocardium and circulatory levels. We and others showed that angiotensin II decreased the ability of the lungs to clear edema and enhanced the fibrosis process phosphorylation of the mitogen-activated protein kinases p38 and p42/44, which are generally involved in cellular responses to pro-inflammatory cytokines. Literature data also indicate the involvement of these effectors in modulating ion channel activity. It has been reported that in heart failure due to mitral stenosis; there were varying degrees of vascular and other associated parenchymal changes such as edema and fibrosis. In this review, we will discuss the effects of cytokines and other inflammatory mediators on the kidneys and the lungs in heart failure; especially their role in renal and alveolar ion channels activity and fluid balance.

Citing Articles

P-selectin glycoprotein ligand-1 and cardiovascular diseases: from a general perspective to an HIV infection context.

Zaongo S, Song Y, Chen Y Front Cardiovasc Med. 2025; 12:1521158.

PMID: 40041169 PMC: 11876174. DOI: 10.3389/fcvm.2025.1521158.


Effects of Thymosin 4 on Myocardial Apoptosis in Burned Rats.

Wu X, Li S, Feng X, Wen H, Meng X, Sun K J Healthc Eng. 2022; 2022:2129629.

PMID: 35281544 PMC: 8913053. DOI: 10.1155/2022/2129629.


Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results.

Szabo T, Frigy A, Nagy E Int J Mol Sci. 2021; 22(23).

PMID: 34884857 PMC: 8657742. DOI: 10.3390/ijms222313053.


Relevance of Neutrophil Neprilysin in Heart Failure.

Prausmuller S, Spinka G, Arfsten H, Stasek S, Rettl R, Bartko P Cells. 2021; 10(11).

PMID: 34831146 PMC: 8616455. DOI: 10.3390/cells10112922.


Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure.

Elgebaly S, Todd R, Kreutzer D, Christenson R, El-Khazragy N, Arafa R Int J Mol Sci. 2021; 22(7).

PMID: 33808213 PMC: 8036979. DOI: 10.3390/ijms22073575.


References
1.
Schiffrin E . Vascular endothelin in hypertension. Vascul Pharmacol. 2005; 43(1):19-29. DOI: 10.1016/j.vph.2005.03.004. View

2.
Kagawa T, Takao T, Horino T, Matsumoto R, Inoue K, Morita T . Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells. Nephrology (Carlton). 2008; 13(4):309-15. DOI: 10.1111/j.1440-1797.2008.00918.x. View

3.
LaPointe M, Isenovic E . Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension. 1999; 33(1 Pt 2):276-82. DOI: 10.1161/01.hyp.33.1.276. View

4.
Ismael-Badarneh R, Guetta J, Klorin G, Berger G, Abu-Saleh N, Abassi Z . The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport. PLoS One. 2015; 10(7):e0134175. PMC: 4521808. DOI: 10.1371/journal.pone.0134175. View

5.
Fujimoto M, Shimizu N, Kunii K, Martyn J, Ueki K, Kaneki M . A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes. 2005; 54(5):1340-8. DOI: 10.2337/diabetes.54.5.1340. View